The relative survival rate of breast cancer patients in Hong Kong is 89.8 percent, just 0.2 percent marginally lower than the United States, which is recognized as the best place to treat breast cancer. In the treatment of stomach cancer, Hong Kong beats Europe and the United States with a five-year survival rate 13 percentage points higher. Hong Kong also leads the world in survival rates for lung, uterine and stomach cancers.
According to a large portion of mainland patients who have been contacted by Hong Kong Adventist Health, the one who performs surgery is Doctor A, the one who performs chemotherapy is Doctor B, and the one who performs radiotherapy is Doctor C. There is not much communication between doctors, and all kinds of treatments they have performed in mainland hospitals are cut off, and they feel that each treatment is just one step at a time, without a comprehensive treatment plan. Some patients, although they try to find information about Hong Kong doctors on the Internet, are unable to understand the medical expertise of the doctors from simple academic information, nor can they find a team of specialized doctors for comprehensive treatment.Hong Kong has a solid foundation in medical research and education, and therefore a group of world-class specialists in cancer treatment. In the process of treating cancer, Hong Kong oncology attending doctors do not fight alone, but conduct multidisciplinary consultation (MDT) to form a professional cancer treatment medical team, which helps patients to obtain diagnostic and treatment advice from experts of multiple disciplines at the same time, and formulate the most comprehensive and reasonable integrated diagnostic and treatment plan to avoid misdiagnosis and mis-treatment, increase the effectiveness of the treatment plan, and enhance the chances of patient's survival.
Hong Kong Adventist Health has treated a liver cancer patient, Mr. Zhou (a pseudonym), who came to Hong Kong for treatment after suffering from cancer. Dr. T, an expert in liver cancer treatment, joined hands with Dr. P, an expert in hepatobiliary surgery, Dr. R, an expert in gastroenterology and Dr. M, an expert in oncology radiology, to conduct a multidisciplinary consultation (MDT), which lasted for three hours, to design a personalized and comprehensive treatment plan for Mr. Zhou. Five years after the completion of all treatments, Mr. Zhou, who comes to Hong Kong for regular check-ups, is no longer the same as he was before his cancer. However, such a long multidisciplinary consultation with senior experts is difficult to realize in China.